Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-14 Chambers Michael Andrew Director Purchase +4,032 $109.89 $443K 246,996
2023-08-11 Chambers Michael Andrew Director Purchase +23,686 $108.05 $2.6M 237,017
2023-08-10 Chambers Michael Andrew Director Purchase +2,206 $104.67 $231K 180,670
2023-08-10 Chambers Michael Andrew Director Purchase +1,091 $105.90 $116K 181,761
2023-08-10 Chambers Michael Andrew Director Purchase +31,570 $106.26 $3.4M 213,331
2023-08-04 Wigzell Hans Lennart Rudolf Director Exercise or conversion +15,000 $29.03 $435K 35,994
2023-08-04 Wigzell Hans Lennart Rudolf Director Sale −15,000 $106.72 $1.6M 20,994
2023-08-04 Wigzell Hans Lennart Rudolf Director Exercise or conversion · Stock Option (right to buy) −15,000 0
2023-06-01 Brown Ryan Edward EVP, General Counsel Shares withheld for taxes −89 $123.60 $11K 28,096
2023-03-30 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −307 $136.66 $42K 26,367
2023-03-08 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −912 $153.19 $140K 70,170
2023-03-08 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −744 $153.19 $114K 34,679
2023-03-08 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −635 $153.19 $97K 28,185
2023-03-08 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −314 $153.19 $48K 26,674
2023-03-06 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −1,370 $157.21 $215K 30,923
2023-03-06 Estepan Ian Michael Chief Financial Officer Grant or award +4,500 35,423
2023-03-06 Estepan Ian Michael Chief Financial Officer Grant or award · Stock Option (right to buy) +27,000 27,000
2023-03-06 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −1,134 $157.21 $178K 66,582
2023-03-06 Rodino-Klapac Louise Head of R&D, CSO Grant or award +4,500 71,082
2023-03-06 Rodino-Klapac Louise Head of R&D, CSO Grant or award · Stock Option (right to buy) +27,000 27,000

Page 15 of 22 · 424 trades